科金特生物科技 COGT
$31.65 +$2.07 (+6.98%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $31.55 -0.30%
开盘$29.53
昨收$29.58
当日区间$28.97 – $31.69
成交量1.48M
市值$5.49B
市盈率（TTM）–
股息率–
COGT 相关新闻
匹配 Cogent Biosciences 或代码 COGT 的头条新闻，按最新排序。
- J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Announces Target Price $62
- Wedbush Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55
- Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $55 正面
- Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $52 正面
- Needham Maintains Cogent Biosciences(COGT.US) With Hold Rating
- Stifel Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45
- UBS Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $60
- Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)
- J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating
- Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52
- A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $45 to $55
- Guggenheim Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52
暂无评论——快来第一个聊聊 COGT。
登录后参与讨论。